These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23510967)

  • 41. Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials.
    Chou R; Carson S; Chan BK
    J Viral Hepat; 2008 Aug; 15(8):551-70. PubMed ID: 18482285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.
    Yu JW; Wang GQ; Sun LJ; Li XG; Li SC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):832-6. PubMed ID: 17565637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin.
    Namikawa M; Kakizaki S; Yata Y; Yamazaki Y; Horiguchi N; Sato K; Takagi H; Mori M
    J Gastroenterol Hepatol; 2012 Jan; 27(1):69-75. PubMed ID: 21649727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic syndrome is associated with poor treatment response to antiviral therapy in chronic hepatitis C genotype 3 patients.
    Aziz H; Gill U; Raza A; Gill ML
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):538-43. PubMed ID: 24642690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.
    Perrakis A; Yedibela S; Schuhmann S; Croner R; Schellerer V; Demir R; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3824-8. PubMed ID: 22172854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment.
    Lewis H; Kunkel J; Axten D; Dalton J; Gardner H; Tippett A; Wynne S; Wilkinson M; Foster GR
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1258-63. PubMed ID: 27487966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment.
    Zickmund SL; Campbell SA; Tirado CF; Zook CL; Weinrieb RM
    J Addict Med; 2012 Sep; 6(3):233-9. PubMed ID: 22790464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?: a narrative systematic review of the evidence base.
    Brew IF; Butt C; Wright N
    Br J Gen Pract; 2013 Dec; 63(617):e842-51. PubMed ID: 24351500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Providing treatment for hepatitis C in an Australian district centre.
    Ewart A; Harrison L; Joyner B; Safe A
    Postgrad Med J; 2004 Mar; 80(941):180-2. PubMed ID: 15016944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implementation of a multidisciplinary, team-based model to treat chronic hepatitis C in the primary care setting: Lessons learned.
    Sokol R; Early J; Barner A; Gottfried S; Gumpert R; Libaridian L; Morrison V; Santamaria A; Shipton L
    Healthc (Amst); 2018 Sep; 6(3):205-209. PubMed ID: 29055770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Audit of amniocentesis from a district general hospital: is it worth it?
    Wiener JJ; Farrow A; Farrow SC
    BMJ; 1990 May; 300(6734):1243-5. PubMed ID: 2354295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Standard of care" treatment for chronic viral C hepatitis in 2013 in Romania.
    Sporea I; Curescu M; Sirli R
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):360-1. PubMed ID: 24079001
    [No Abstract]   [Full Text] [Related]  

  • 53. Audit of necropsies in a British district general hospital.
    Harris MD; Blundell JW
    J Clin Pathol; 1991 Oct; 44(10):862-5. PubMed ID: 1960222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Services for liver disease in district general hospitals in the UK: a national questionnaire-based survey.
    Williams MJ; Salmon C; Austin AS; Freeman JG
    Clin Med (Lond); 2009 Feb; 9(1):26-9. PubMed ID: 19271596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thyroid register audit: a district general hospital experience.
    Tan SY; Gill GV; Hales T
    Postgrad Med J; 1992 Jun; 68(800):483-4. PubMed ID: 1437937
    [No Abstract]   [Full Text] [Related]  

  • 56. Whither secondary care?
    Dornan T
    Diabet Med; 1994 Nov; 11(9):822-4. PubMed ID: 7705016
    [No Abstract]   [Full Text] [Related]  

  • 57. HCV infection should be managed in specialist centres.
    Brown JL
    Gut; 2002 Nov; 51(5):626-7. PubMed ID: 12377797
    [No Abstract]   [Full Text] [Related]  

  • 58. Audit of necropsies in a British district general hospital.
    Mears TP; Coppen MJ; Thomas SM
    J Clin Pathol; 1992 Jun; 45(6):549. PubMed ID: 1624614
    [No Abstract]   [Full Text] [Related]  

  • 59. Rules in the clinical setting: pros and cons.
    McKie J
    Health Care Anal; 1998 Dec; 6(4):305-7. PubMed ID: 10345936
    [No Abstract]   [Full Text] [Related]  

  • 60. National Audit Office report slams standard of diabetes care in England.
    Nurs Stand; 2012 May; 26(39):10. PubMed ID: 28072105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.